SPRINGFIELD — When Dr. Mark Kenton does his daily rounds, he’s taking the pulse of Mercy Medical Center’s entire Department of Emergency Medicine. Kenton wants to know how many patients are there, how ...

Patients with advanced cancer who also had cardiac defibrillators were more likely than those without these implants to receive aggressive end-of-life care, a team led by UT Southwestern Medical ...

New results from a clinical trial co-led by UCLA investigators demonstrate how treating desmoplastic melanoma, a rare and ...

Geneos Therapeutics, a clinical-stage biotherapeutics company developing personalized immunotherapies for cancer (PICs), today announced that two patients with aggressive cancers – one with ...

Pembrolizumab works by blocking a mechanism that cancer cells use to evade detection by the immune system, according to Drugs.com. The U.S. Food and Drug Administration (FDA) first approved it in 2014 ...

Patients who go to the emergency room (ER) with chest pain often receive unnecessary tests to evaluate whether they are having a heart attack, a practice that provides no clinical benefit and adds ...

Researchers at The University of Texas MD Anderson Cancer Center have identified a targetable driver of brain metastases in ...

A new experimental vaccine could slow down triple negative breast cancer and reduce its recurrence after treatment.

—Despite the fact that about one-third of patients with ERBB2-positive breast cancer develop brain metastases, not much is known about outcomes among patients who have disease limited to the central ...

Many Medicare patients with advanced cancer receive potentially aggressive treatment at the expense of supportive care, according to a study that analyzed Medicare records. The study, published in ...

Marginal zone lymphoma treatment evolves with promising CAR T-cell therapies, addressing unmet needs in aggressive cases and improving patient outcomes.

An experimental vaccine could offer fresh hope to women diagnosed with an aggressive and hard-to-treat form of breast cancer, new research suggests. The vaccine appears to be safe and effective ...